ReviewCancer research2022
Metabolic Reprogramming in Hematologic Malignancies: Advances and Clinical Perspectives.
Zhuoya Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it
ReviewCancer research2022
Zhuoya Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.